ERAMKAFUSP ALFA
UNII N7FO1V18PR

Substance Identification & Data

This profile provides standardized clinical and technical data for Eramkafusp Alfa, uniquely identified by the FDA Unique Ingredient Identifier (UNII) N7FO1V18PR.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2388499-82-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
N7FO1V18PR
CAS Registry Number
2388499-82-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ERAMKAFUSP ALFA
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
11590
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Eramkafusp Alfa. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ERAMKAFUSP ALFA

Common Names & Synonyms

ANTI-CD20 MONOCLONAL ANTIBODY-INTERFERON-ALPHA FUSION PROTEIN IGN002
ERAMKAFUSP ALFA [INN]
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 ANTIGEN) (HUMAN-MUS MUSCULUS .GAMMA.1-CHAIN) FUSION PROTEIN WITH PEPTIDE LINKER (SGGGGS) FUSION PROTEIN WITH INTERFERON .ALPHA.2B (HUMAN), DISULFIDE WITH HUMAN-MUS MUSCULUS .KAPPA.-CHAIN, DIMER

Technical Codes

IGN002
IGN-002